Response, complications and risk of leukemic transformation of phosphorus-32 treatment in Philadelphia-negative chronic myeloproliferative syndromes

1. Tobalina Larrea, I.
2. Cuetos Fernández, J.
3. Mendizabal Abad, A.
4. Montero de la Peña, A.
5. García Hernández, D.
6. Portilla Quatrociocchi, G.H.
7. Jiménez Alonso, M.
8. Menchaca Echevarria, M.C.